Pharmaceuticals Ultrasector Correlations
PHPSX Fund | USD 19.81 0.30 1.49% |
The current 90-days correlation between Pharmaceuticals Ultrasector and Guidemark Large Cap is 0.3 (i.e., Weak diversification). The correlation of Pharmaceuticals Ultrasector is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Pharmaceuticals Ultrasector Correlation With Market
Poor diversification
The correlation between Pharmaceuticals Ultrasector Pr and DJI is 0.69 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and DJI in the same portfolio, assuming nothing else is changed.
Pharmaceuticals |
Moving together with Pharmaceuticals Mutual Fund
0.67 | UMPIX | Ultramid Cap Profund | PairCorr |
0.68 | MDPSX | Mid Cap Profund | PairCorr |
0.62 | MGPIX | Mid Cap Growth | PairCorr |
0.81 | FNPIX | Financials Ultrasector | PairCorr |
0.61 | RYVYX | Nasdaq 100 2x Downward Rally | PairCorr |
0.61 | RYVLX | Nasdaq 100 2x Downward Rally | PairCorr |
0.61 | RYCCX | Nasdaq 100 2x Downward Rally | PairCorr |
0.61 | UOPIX | Ultra Nasdaq 100 Downward Rally | PairCorr |
0.61 | UOPSX | Ultranasdaq 100 Profund Downward Rally | PairCorr |
0.63 | RMQHX | Monthly Rebalance | PairCorr |
0.63 | RMQAX | Monthly Rebalance | PairCorr |
0.62 | RMQCX | Monthly Rebalance | PairCorr |
0.63 | DXQLX | Direxion Monthly Nasdaq | PairCorr |
0.76 | INPSX | Internet Ultrasector | PairCorr |
0.82 | FTYPX | Fidelity Freedom Index | PairCorr |
0.81 | FFBTX | Fidelity Freedom Blend | PairCorr |
0.69 | GCAVX | Gmo Small Cap | PairCorr |
0.88 | GQLOX | Gmo Quality Fund | PairCorr |
0.75 | GMCQX | Gmo Equity Allocation | PairCorr |
Moving against Pharmaceuticals Mutual Fund
0.62 | AFBIX | Access Flex Bear | PairCorr |
0.62 | UCPIX | Ultrashort Small Cap Steady Growth | PairCorr |
0.59 | SHPSX | Short Small Cap | PairCorr |
0.45 | SRPIX | Short Real Estate | PairCorr |
0.43 | GAAVX | Gmo Alternative Allo | PairCorr |
Related Correlations Analysis
0.62 | 0.4 | 0.54 | 0.15 | 0.68 | 0.64 | GMLVX | ||
0.62 | 0.78 | 0.64 | 0.2 | 0.82 | 0.98 | DHGCX | ||
0.4 | 0.78 | 0.65 | 0.47 | 0.75 | 0.69 | MGGNX | ||
0.54 | 0.64 | 0.65 | 0.79 | 0.89 | 0.6 | TACLX | ||
0.15 | 0.2 | 0.47 | 0.79 | 0.55 | 0.15 | SGICX | ||
0.68 | 0.82 | 0.75 | 0.89 | 0.55 | 0.78 | ARECX | ||
0.64 | 0.98 | 0.69 | 0.6 | 0.15 | 0.78 | ANAGX | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Pharmaceuticals Mutual Fund performing well and Pharmaceuticals Ultrasector Mutual Fund doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Pharmaceuticals Ultrasector's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
GMLVX | 0.72 | 0.05 | 0.07 | 0.04 | 0.94 | 1.57 | 5.51 | |||
DHGCX | 0.18 | 0.00 | 0.23 | 0.35 | 0.18 | 0.37 | 1.46 | |||
MGGNX | 0.20 | (0.01) | 0.00 | (0.34) | 0.00 | 0.35 | 1.96 | |||
TACLX | 0.63 | 0.05 | 0.07 | 0.00 | 0.80 | 1.28 | 3.10 | |||
SGICX | 0.53 | 0.02 | 0.00 | (0.02) | 0.00 | 1.09 | 2.61 | |||
ARECX | 0.70 | 0.06 | 0.08 | 0.03 | 0.89 | 1.52 | 4.45 | |||
ANAGX | 0.18 | 0.01 | 0.22 | 0.86 | 0.14 | 0.44 | 1.46 |